Proniras
proniras.com
Actively hiring
Neurology & CNS Therapeutics
Prescription Drugs
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$11.2M
2 rounds on record
Latest round
$6.9M
Venture round · Dec 2023 · 2 yr ago
Team
2
US Form 5500 (plan participants) · Dec 2024
The money's age
Long since its last round
33 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 15, 2023
Raised a round Venture round $6.9M · SEC Form D
Aug 22, 2017
Raised a round Venture round $4.3M · SEC Form D
2016
Founded
Tractionpublic signals, read monthly
Web presence
top 13%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2023 | $6.9M | — | SEC Form D |
| Venture round | Aug 2017 | $4.3M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Proniras Corp | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Lindsay RayleExecutive OfficerSEC Form D
David SchubertExecutive OfficerSEC Form D
Steve GillisDirectorSEC Form D
Thong LeExecutive Officer, DirectorSEC Form D
Christopher ToombsExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
backs Deepcure
Similar startupsby what they do, their industry and backers
Biomia rationally engineers nature-inspired novel small molecule therapeutics to treat CNS disorders.
Minoryx is focused on the discovery and development of novel treatments for severe, orphan diseases of the central nervous system with high…
Luxna Biotech is a preclinical-stage Japanese biotechnology company that develops antisense oligonucleotide (ASO) therapeutics using novel…
ABOUT US CONNECTA Therapeutics S.L. is a clinical-stage biotech company pioneering first-in-class neuroplasticity modulators to address…
Brenig Therapeutics develops innovative small-molecule therapies for neurodegenerative diseases, including LRRK2 inhibitors targeting…
Atavistik Bio is a clinical stage biotechnology company developing novel allosteric therapeutics. Our approach enables selective modulation…
Overview
About Us Proniras Corporation ("Proniras") is a clinical-stage biotechnology company focused on the development of novel small-molecule therapeutics for the treatment of substance use and specialty central nervous system (CNS) disorders.
People
Lindsay Rayle
Executive Officer
David Schubert
Executive Officer
Steve Gillis
Director
Thong Le
Executive Officer, Director
Christopher Toombs
Executive Officer
Asish Xavier
Director
Joel Marcus
Director
M. Erwin
Director
Steven Gillis
Director
Atul Saran
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1